TEVA is the world's largest producer and distributor of generic pharmaceuticals. TEVA is among the Top 20 pharmaceutical companies in the world. It is present in 60 nations with over 38,000 employees worldwide. TEVA has major manufacturing and marketing facilities in Israel, Europe and United States of America. It is a leading global supplier of the vital raw materials of the drug manufacturing industry known as the Active Pharmaceutical Ingredients.
The order this company entered each market — oldest to newest
Teva collaborates on skin disease treatment, releases targets
Teva to present at healthcare conferences
Sign up to see the full signal feed
How Pacific Healthcare (Philippines), Inc.'s international expansion compares to its competitors
Pacific Healthcare (Philippines), Inc.YouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Pacific Healthcare (Philippines), Inc.You | 0 | 0 | 0% | 0 | 11 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Tel Aviv Stock Exchange indices rose, with Teva and Next Vision showing significant gains. Bank stocks weakened.
Samsung Bioepis launches Epclisa, a biosimilar of Soliris, in the US market through partner Teva. Priced 30% lower than Soliris, it aims to reduce healthcare costs for rare disease treatments.
Pfizer's oral CGRP antagonist Nurtec approved in Korea for acute and preventive migraine treatment, intensifying competition in the migraine drug market against existing treatments like Aimovig and Ajovy.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Pacific Healthcare (Philippines), Inc.'s business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
